About the Authors
- Yuji Nakada
-
Contributed equally to this work with: Yuji Nakada, Thomas G. Stewart
Affiliation Department of Pathology and Simmons Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States of America
- Thomas G. Stewart
-
Contributed equally to this work with: Yuji Nakada, Thomas G. Stewart
Affiliation Departments of Medicine and Genetics, The Lineberger Comprehensive Cancer Center and University of North Carolina, Chapel Hill, North Carolina, United States of America
- Christopher G. Peña
-
Affiliation Department of Pathology and Simmons Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States of America
- Song Zhang
-
Affiliation Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America
- Ni Zhao
-
Affiliation Departments of Medicine and Genetics, The Lineberger Comprehensive Cancer Center and University of North Carolina, Chapel Hill, North Carolina, United States of America
- Nabeel Bardeesy
-
Affiliation Massachusetts General Hospital Cancer Center and Harvard Medical School, Cambridge, Massachusetts, United States of America
- Norman E. Sharpless
-
Affiliation Departments of Medicine and Genetics, The Lineberger Comprehensive Cancer Center and University of North Carolina, Chapel Hill, North Carolina, United States of America
- Kwok-Kin Wong
-
Affiliation Department of Medicine, Harvard of Medical School and Dana Farber Cancer Institute, Boston, Massachusetts, United States of America
- D. Neil Hayes
-
* E-mail: hayes@med.unc.edu (DNH); diego.castrillon@utsouthwestern.edu (DHC)
Affiliation Departments of Medicine and Genetics, The Lineberger Comprehensive Cancer Center and University of North Carolina, Chapel Hill, North Carolina, United States of America
- Diego H. Castrillon
-
* E-mail: hayes@med.unc.edu (DNH); diego.castrillon@utsouthwestern.edu (DHC)
Affiliation Department of Pathology and Simmons Cancer Center, UT Southwestern Medical Center, Dallas, Texas, United States of America
Competing Interests
DC, KW, NB and NS are inventors on an application (United States patent pending) of DNA-based methods to employ LKB1 status for diagnostic and prognostic clinical tests. This invention does not utilize the methods or antibody described in this manuscript. These investigators are paid consultants of Molecular MD (Portland, OR), which has a license agreement with these authors' respective academic institutions. NH is an inventor on an application (United States patent pending) for the use of LKB1 as a prognostic factor – this invention also does not utilize the methods or antibody described in this manuscript.
Author Contributions
Conceived and designed the experiments: YN TS CP SZ NB NS KW NH DC. Performed the experiments: YN TS CP SZ. Analyzed the data: YN TS CP SZ NB NS KW NH DC NZ. Wrote the paper: YN TS NH DC.